This study tests a more intense chemotherapy regimen (mFOLFOXIRI) plus the drug bevacizumab against a standard regimen (mFOLFOX-6) plus bevacizumab as a first treatment for people with advanced colorectal cancer that cannot be removed by surgery. The trial includes 528 participan…
Phase: PHASE3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC